92 related articles for article (PubMed ID: 37084725)
21. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
22. Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants.
Chiu MC; Li C; Liu X; Song W; Wan Z; Yu Y; Huang J; Xiao D; Chu H; Cai JP; To KK; Yuen KY; Zhou J
mBio; 2022 Aug; 13(4):e0194422. PubMed ID: 35938726
[TBL] [Abstract][Full Text] [Related]
23. Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues.
Massoth LR; Desai N; Szabolcs A; Harris CK; Neyaz A; Crotty R; Chebib I; Rivera MN; Sholl LM; Stone JR; Ting DT; Deshpande V
Am J Surg Pathol; 2021 Jan; 45(1):14-24. PubMed ID: 32826529
[TBL] [Abstract][Full Text] [Related]
24. CCR2 Signaling Restricts SARS-CoV-2 Infection.
Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
[TBL] [Abstract][Full Text] [Related]
25. Adult Stem Cell-derived Complete Lung Organoid Models Emulate Lung Disease in COVID-19.
Tindle C; Fuller M; Fonseca A; Taheri S; Ibeawuchi SR; Beutler N; Katkar G; Claire A; Castillo V; Hernandez M; Russo H; Duran J; Crotty Alexander LE; Tipps A; Lin G; Thistlethwaite PA; Chattopadhyay R; Rogers TF; Sahoo D; Ghosh P; Das S
bioRxiv; 2021 May; ():. PubMed ID: 33106807
[TBL] [Abstract][Full Text] [Related]
26. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
27. Apical-Out Human Airway Organoids Modeling SARS-CoV-2 Infection.
Chiu MC; Zhang S; Li C; Liu X; Yu Y; Huang J; Wan Z; Zhu X; Zhou J
Viruses; 2023 May; 15(5):. PubMed ID: 37243252
[TBL] [Abstract][Full Text] [Related]
28. Antemortem vs Postmortem Histopathologic and Ultrastructural Findings in Paired Transbronchial Biopsy Specimens and Lung Autopsy Samples From Three Patients With Confirmed SARS-CoV-2.
Gagiannis D; Umathum VG; Bloch W; Rother C; Stahl M; Witte HM; Djudjaj S; Boor P; Steinestel K
Am J Clin Pathol; 2022 Jan; 157(1):54-63. PubMed ID: 34463314
[TBL] [Abstract][Full Text] [Related]
29. Human Organoids as a Promising Platform for Fighting COVID-19.
Chen D; Su X; Chen H; Chen S; Zhao Y; Wei W
Int J Biol Sci; 2022; 18(3):901-910. PubMed ID: 35173525
[TBL] [Abstract][Full Text] [Related]
30. Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction.
Katsura H; Sontake V; Tata A; Kobayashi Y; Edwards CE; Heaton BE; Konkimalla A; Asakura T; Mikami Y; Fritch EJ; Lee PJ; Heaton NS; Boucher RC; Randell SH; Baric RS; Tata PR
Cell Stem Cell; 2020 Dec; 27(6):890-904.e8. PubMed ID: 33128895
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids.
Jansen J; Reimer KC; Nagai JS; Varghese FS; Overheul GJ; de Beer M; Roverts R; Daviran D; Fermin LAS; Willemsen B; Beukenboom M; Djudjaj S; von Stillfried S; van Eijk LE; Mastik M; Bulthuis M; Dunnen WD; van Goor H; Hillebrands JL; Triana SH; Alexandrov T; Timm MC; van den Berge BT; van den Broek M; Nlandu Q; Heijnert J; Bindels EMJ; Hoogenboezem RM; Mooren F; Kuppe C; Miesen P; Grünberg K; Ijzermans T; Steenbergen EJ; Czogalla J; Schreuder MF; Sommerdijk N; Akiva A; Boor P; Puelles VG; Floege J; Huber TB; ; van Rij RP; Costa IG; Schneider RK; Smeets B; Kramann R
Cell Stem Cell; 2022 Feb; 29(2):217-231.e8. PubMed ID: 35032430
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G
J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676
[TBL] [Abstract][Full Text] [Related]
33. Mediators of Obesity Do Not Influence SARS-CoV-2 Infection or Activation of Primary Human Lung Microvascular Endothelial Cells
Ter Ellen BM; Niewold J; Flikweert A; Muller Kobold AC; Heeringa P; van Meurs M; Smit JM; van der Voort PHJ; Rodenhuis-Zybert IA; Moser J
Front Immunol; 2022; 13():879033. PubMed ID: 35837388
[TBL] [Abstract][Full Text] [Related]
34. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
[TBL] [Abstract][Full Text] [Related]
35. Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer.
Shuai H; Chu H; Hou Y; Yang D; Wang Y; Hu B; Huang X; Zhang X; Chai Y; Cai JP; Chan JF; Yuen KY
J Infect; 2020 Oct; 81(4):e1-e10. PubMed ID: 32707230
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
[TBL] [Abstract][Full Text] [Related]
37. Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures.
Kulasinghe A; Tan CW; Ribeiro Dos Santos Miggiolaro AF; Monkman J; SadeghiRad H; Bhuva DD; Motta Junior JDS; Busatta Vaz de Paula C; Nagashima S; Baena CP; Souza-Fonseca-Guimaraes P; de Noronha L; McCulloch T; Rossi GR; Cooper C; Tang B; Short KR; Davis MJ; Souza-Fonseca-Guimaraes F; Belz GT; O'Byrne K
Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34675048
[TBL] [Abstract][Full Text] [Related]
38. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
39. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
Das AB
BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
[TBL] [Abstract][Full Text] [Related]
40. NOTCH signaling in COVID-19: a central hub controlling genes, proteins, and cells that mediate SARS-CoV-2 entry, the inflammatory response, and lung regeneration.
Baindara P; Sarker MB; Earhart AP; Mandal SM; Schrum AG
Front Cell Infect Microbiol; 2022; 12():928704. PubMed ID: 35992174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
